Skip to main content

Table 2 Patient characteristics longitudinal analysis

From: Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer

  N = 11
Age at Tx (years)a 65.4 (47–75)
Gender (male) 8 (72.7%)
Years between Tx and first cSCCa 2.6 (1.1–11.5)
Years between Tx and post-Tx samplea 2.1 (0.3–13.0)
CMV acceptor
 Negative 4 (36.4%)
 Positive 7 (63.6%)
CMV donor
 Negative 7 (63.6%)
 Positive 4 (36.4%)
HLA mismatchesa 2 (0–6)
Type of immunosuppression directly after transplantation
 Corticosteroids 10 (90.9%)
 Tacrolimus 10 (90.9%)
 MMF 10 (90.9%)
 Cyclosporine 1 (9.1%)
 Sirolimus 1 (9.1%)
 Basiliximab induction 3 (27.3%)
 ATG induction 1 (9.1%)
ESRD diagnosis
 Polycystic kidney 5 (45.5%)
 Hypertension 1 (9.1%)
 Other 5 (45.5%)
Dialysis pre-transplantation
 Yes 8 (72.7%)
 No 3 (27.3%)
  1. aMedian and range
  2. cSCC cutaneous squamous cell carcinoma, CMV cytomegalovirus, ESDR end-stage renal disease